Current Report Filing (8-k)
July 29 2022 - 12:16PM
Edgar (US Regulatory)
0000727346
false
0000727346
2022-07-25
2022-07-25
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): July 25, 2022
SELECTIS
HEALTH, INC.
(Exact Name of Registrant as Specified
in its Charter)
Utah
|
|
0-15415
|
|
87-0340206
|
(State
or other jurisdiction
of incorporation) |
|
Commission
File
Number |
|
(I.R.S.
Employer
Identification number) |
8480
E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
☐ |
Written
communications pursuant to Rule 425 under the Securities Act |
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each Class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM
5.02: |
ADOPTION
OF COMMITTEE CHARTERS AND APPOINTMENT OF COMMITTEE MEMBERS |
On
July 25, 2022 the Board of Directors of Selectis Health, Inc, a Utah corporation (the “Company”) approved and adopted the
following committee charters and policies:
Audit
Committee Charter
Nominating
and Governance Committee Charter
Compensation
Committee Charter
Code
of Conduct and Ethics Policy
Document
Retention Policy
Whistleblower
Policy
Copies
of the above-noted charters and policies are filed herewith as Exhibits 10.1 through 10.6 respectively.
Also
on July 25, 2022, the Board of Directors approved the following appointments to the Board’s standing committees:
Audit
Committee:
David
Furstenberg: Chairman and Audit Committee Financial Expert
Clifford
Neuman
Adam
Desmond
Compensation
Committee
Clifford
Neuman: Chairman
David
Furstenberg
Adam
Desmond
Nominating
and Governance Committee
Adam
Desmond: Chairman
David
Furstenberg
Clifford
Neuman
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
|
Selectis
Health, Inc
|
|
|
(Registrant) |
|
|
|
|
Dated:
July 29, 2022 |
/s/
Lance Baller
|
|
|
Lance
Baller, CEO |
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jul 2023 to Jul 2024